Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cryo Cell International (CCEL) Net Margin (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Net Margin for 16 consecutive years, with 106.08% as the latest value for Q4 2025.

  • On a quarterly basis, Net Margin fell 7896.0% to 106.08% in Q4 2025 year-over-year; TTM through Nov 2025 was 21.96%, a 2223.0% decrease, with the full-year FY2025 number at 21.96%, down 2223.0% from a year prior.
  • Net Margin was 106.08% for Q4 2025 at Cryo Cell International, down from 9.58% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 16.25% in Q2 2021 to a low of 213.97% in Q4 2023.
  • A 5-year average of 10.71% and a median of 8.23% in 2022 define the central range for Net Margin.
  • Peak YoY movement for Net Margin: crashed -22476bps in 2023, then surged 18685bps in 2024.
  • Cryo Cell International's Net Margin stood at 8.71% in 2021, then surged by 224bps to 10.79% in 2022, then plummeted by -2083bps to 213.97% in 2023, then surged by 87bps to 27.12% in 2024, then tumbled by -291bps to 106.08% in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Net Margin are 106.08% (Q4 2025), 9.58% (Q3 2025), and 4.49% (Q2 2025).